+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bladder Cancer Drugs Market Research Reports

Muscle-invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Muscle-invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 321 Pages
  • Global
Urothelial Carcinoma Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Urothelial Carcinoma Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • December 2023
  • 245 Pages
  • Global
Bladder Cancer: Epidemiology Forecast to 2033 - Product Thumbnail Image

Bladder Cancer: Epidemiology Forecast to 2033

  • Report
  • October 2024
  • 70 Pages
  • Global
From
Methotrexate (CAS 59-05-2) Global Market Research Report 2024 - Product Thumbnail Image

Methotrexate (CAS 59-05-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Bropirimine (CAS 56741-95-8) Global Market Research Report 2024 - Product Thumbnail Image

Bropirimine (CAS 56741-95-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Urothelial Carcinoma Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Urothelial Carcinoma Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Non-Muscle Invasive Bladder Cancer (NMIBC) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Non-Muscle Invasive Bladder Cancer (NMIBC) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Investigation Report on China's Doxorubicin Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Doxorubicin Market 2021-2025

  • Report
  • June 2021
  • China
From
Doxorubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Formulation, Application, and Distribution Channel - Product Thumbnail Image

Doxorubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Formulation, Application, and Distribution Channel

  • Report
  • July 2022
  • 199 Pages
  • Global
From
Doxorubicin Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027) - Product Thumbnail Image

Doxorubicin Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

  • Report
  • August 2022
  • 115 Pages
  • Global
From
Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 78 Pages
  • Asia Pacific
From
Bladder Cancer Therapeutics and Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025) - Product Thumbnail Image

Bladder Cancer Therapeutics and Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

  • Report
  • August 2020
  • 115 Pages
  • Global
From
Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
IMFINZI Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

IMFINZI Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Metastatic Urothelial Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Metastatic Urothelial Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Urothelial Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Urothelial Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Advanced Urothelial Carcinoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Advanced Urothelial Carcinoma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Low-Grade Upper Tract Urothelial Cancer (LG UTUC) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Low-Grade Upper Tract Urothelial Cancer (LG UTUC) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Balversa - Drug Insight, 2019 - Product Thumbnail Image

Balversa - Drug Insight, 2019

  • Report
  • July 2019
  • Global
From
Bladder Cancer Therapeutics and Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Bladder Cancer Therapeutics and Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • October 2023
  • 174 Pages
  • Global
From
Loading Indicator

The Bladder Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat bladder cancer. Bladder cancer is a type of cancer that affects the urinary tract and is the sixth most common type of cancer in the United States. Common treatments for bladder cancer include chemotherapy, radiation therapy, and surgery. Drugs used to treat bladder cancer are typically classified as either targeted therapies or immunotherapies. Targeted therapies are designed to target specific molecules or pathways in the body that are involved in the growth and spread of cancer cells. Immunotherapies are designed to stimulate the body’s own immune system to fight cancer cells. Some of the major companies in the Bladder Cancer Drugs market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development and sale of drugs used to treat bladder cancer. Show Less Read more